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Genes  controlling  specific  immune  responses  (Ir  genes) 1 to  various  exogenous 
antigens have been identified and reside within the major histocompatibility complex 
(MHC) (1). Ir genes also influence susceptibility to a variety of experimental autoim- 
mune diseases, most notably thyroiditis (2), myasthenia gravis (3), collagen arthritis 
(4),  polyneuritis  (5),  and  encephalomyelitis  (6-18).  Experimental  automimmune 
encephalomyelitis (EAE) is an acute inflammatory and demyelinating disease medi- 
ated by the cellular component of the immune response. EAE has been well studied 
in a  number of laboratory species ranging from rodents to primates,  because  it is 
easily  induced  with  a  single  injection  inoculum of purified  myelin-basic protein 
(MBP) (19) in an oil-based adjuvant containing mycobacteria (e.g., Freund's complete 
adjuvant  [FCA]).  This disease is associated with a  T  cell-dependent  delayed-type 
hypersensitivity (DTH) reaction to MBP (19). Both induction (20) and effector phases 
(21,  22)  of the  disease  are  T  lymphocyte dependent.  Transfer  of EAE  can  be 
accomplished with MBP-sensitized T  cells (22),  but transfer with serum containing 
antibody to MBP has not been successful. 
Studies using rats show strong association between susceptibility to EAE and MHC, 
but background (i.e., non-MHC) genes are also believed to be involved (14,  15). In 
guinea pigs, strain 13 is highly susceptible, whereas strain 2 is relatively resistant, and 
this finding correlates with in vivo and in vitro assessment of lymphocyte reactivity to 
MBP (10). A number of early investigators found it difficult to induce EAE in outbred 
and inbred strains of mice (6). The use of Bordetella  pertussis vaccine accentuated the 
development  of EAE  in  some  strains  of mice,  but  others  remained  resistant  (7). 
Analysis of inbred strains (9,  12, 18) has suggested that two specific H-2 haplotypes, 
H-2  ~ and H-2  q, confer susceptibility, whereas others are refractory to the development 
of EAE. 
Susceptibility to  EAE  appeared  to be  solely controlled by the appropriate  H-2 
* Supported by grant 1256-A-2 from the National Multiple Sclerosis Society,  and grant CA-22662 from 
the National Institutes of Health. 
:~ Scholar of the Leukemia Society of America, Inc. 
§ Recipient of a faculty research award of the American Cancer Society. 
Abbreviations  used  in  this paper:  CNS,  central  nervous system;  DTH,  delayed-type hypersensitivity; 
EAE, experimental autoimmune encephalomyelitis; FCA,  Freund's .complete adjuvant;  Ir, immune re- 
sponse; HSF, histamine sensitivity factor of B. pertussis  (pertussigen); MBP, myelin basic protein; MHC, 
major  histocompatibility complex;  MSCH,  mouse  spinal  cord  homogenate;  VAA,  vasoactive amines 
(serotonin and histamine); VAAS, VAA sensitization. 
J. Exo. MED. © The Rockefeller trniversity Press  • 0022-1007/82/07/0031 / 10 $1.00  31 
Volume 155  July 1982  31-40 32  ACUTE  AUTOIMMUNE  ENCEPHALOMYELITIS  IN MICE 
haplotype until the more recent use of H-2 congenic strains of mice to controversial 
results, in that not all H-2 congenic mice bearing responder H-28 and H-2 q haplotypes 
were  susceptible to  EAE  (12,  18).  This  suggests  that  other background  or non-H-2 
genes also play a  role in EAE susceptibility. 
We have  determined that a  combination of an appropriate H-2  haplotype and a 
second dominant  gene, the gene for vasoactive amine sensitization (VAAS), confers 
susceptibility to acute EAE in mice. Susceptible strains bear H-2 ~ and H-2 q haplotypes 
and  undergo  VAAS with  administration of B.  pertussis  (an  adjuvant  crucial  to  the 
development of acute EAE  in mice); resistant strains are not  sensitive to B. pertussis 
VAAS  or  lack  the  appropriate  H-2  type.  Fa  hybrids  between  H-2  nonresponder/ 
VAAS-sensitive mice and H-2 responder/VAAS-resistant mice are fully susceptible to 
EAE and VAAS. The role of these genes on the expression of acute and chronic EAE 
in mice is discussed. 
Materials  and  Methods 
Animals.  Mice  used  in  these studies were  obtained  from  several sources:  Dr.  Margaret 
Holmes kindly provided several inbred and congenic strains for the studies at The Walter and 
Eliza Hall Institute. Some recombinant strains were from the University of Southern California 
(USC) Immunogenetics mouse colony, and (SJL ×  BALB/c)Fa, (SOIL X NZB)F1, and (SJL × 
SWR)F1 hybrid strains were obtained from The Jackson Laboratory, Bar Harbor, ME. Outbred 
((2FW) mice were obtained from Camm Labs; some inbred F1 hybrids were produced in the 
US(2 Vivaria. The DDD strain was obtained from Dr. K. Susuki (University of Tokyo), and 
H-2 typed KTD ? from Dr. S. Sakai (Natsuume) of the Cancer Research Institute of Kanazawa 
University and Ms. K. Sudo (University of Tokyo). Mice of both sexes at 6-10 wk of age were 
used for the studies. 
Induction and Evaluation of EAE.  Mice were immunized with mouse spinal cord homogenate 
(MSCH),  10 mg dry weight suspended in saline, emulsified in equal volume of FCA supple- 
mented with 5 mg/ml Mycobacterium tuberculosis (H37RA; Difco Laboratories, Detroit, MI). All 
four  footpads  were  injected,  the  total  inoculum  volume  being  0.1  ml.  For  the  complete 
"encephalitogenic challenge," two injections of B. pertussis  (25 ×  10  a cells) were given immedi- 
ately thereafter and again 48 h later. Mice were examined daily for signs of EAE scored on a 
scale of 0-3: 0, no disease;  1, tail atonia, slight hind limb weakness;  2,  hind limb paralysis, 
incontinence of bladder; and 3, moribund state or death due to EAE. Histological assessment 
of EAE was made on  mid-sagittal paraffin sections of brain and  spinal cord, stained with 
hematoxylin and eosin. Without knowledge of the injection regime, the size and frequency of 
perivascular mononuclear infiltrates in the white matter of the central nervous systems (CNS) 
were graded on  a  scale of 0-3  as:  0,  no lesions;  1,  few lesions, mainly leptomeningeal and 
ependymal; 2, numerous infiltrates in the white matter of the brain stem, cerebellum and spinal 
cord; and 3, florid lesions throughout the brain and spinal cord white matter (23). 
Vasoactive Amine (VAA) Sensitivity deteminations.  B. pertussis has been demonstrated to cause a 
"hypersensitivity" to both VAA serotonin and histamine (24).  For the sake of simplicity, we 
chose to test VAAS with only histamine. Histamine sensitization due to B. pertussis vaccine was 
determined by intraperitoneal injection of 1 mg histamine free base (denoted as challenge) in 
0.2-0.5 ml saline 3-4 d after the initial inoculation of B. pertussis  vaccine (25).  Deaths (due to 
hypotensive and  hypovolemic shock)  were  recorded  for  the  next  2  h,  and  the  results  are 
expressed  as  number  of deaths  divided by  the  total  number  of animals  challenged.  Mice 
challenged with histamine without treatment with B. pertussis  inoculation served as a negative 
control. 
Results 
VAA Sensitivity.  Several strains of mice were examined for their naturaP.sensitivity 
to VAA  (histamine  and  serotonin)  by titration of LD50  levels  (Table  I).  Groups of D.  S.  LINTHICUM AND J.  A.  FRELINGER 
TABLE  I 
VAA LDso Determinations* on Normal Mice 
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Mouse strain 
Histamine  Serotonin 
i.v.  i.p.  i.v.  i.p. 
mg  mg 
SJL  0.3  0.3  1.2  -- 
BALB/c  2.5  17.0  2.5  -- 
SWR  3.0  12.0  2.0  20.0 
(SJL x BALB/c)F1  2.5  15.5  2.5  15.0 
(SJL x SWR)Fx  2.5  15.0  --  15.0 
(SJL x NZB)F~  3.0  20.0  4.0'  20.0 
a 10.S(9R)  --  20.0  --  -- 
* Determinations were made  using groups (N --- 8) of normal mice (mean weight 
20 g). 
eight mice, average weight 20 g, were tested over a  wide range of doses of histamine 
and  serotonin  by  intravenous  or intraperitoneal  administration,  and  2  h  later  the 
deaths  (due  to hypotensive and  hypovolemic shock)  were recorded.  SJL mice were 
determined  to  be  very  sensitive  to  both  VAA  tested.  For  example,  the  LDs0  for 
histamine  intravenously  in  SJL mice is  ~10  times  lower  than  that  determined  for 
other strains.  Other mouse strains tested  (e.g., BALB/c) were fairly resistant  to both 
VAA  (e.g.,  histamine  intraperitoneaUy  LDs0  --  12-20  mg,  which  is  equivalent  to 
~600-1,000  mg/kg).  The  natural  high  level  resistance  to  VAA  induced  shock  is 
inherited  in a  dominant  fashion as seen by the resistance of the  (SJL ×  BALB/c)FI 
hybrids to shock. 
B.  pertussis-induced Histamine  Hypersensitivity.  The  administration  of B.  pertusis or 
purified  histamine  sensitivity  factor  (HSF)  to  certain  strains  of mice  will  cause  a 
"histamine and serotonin hypersensitivity"  (23, 26). We tested a  number of different 
strains  and  F1  hybrids  for  induced  histamine  sensitivity  after  administration  of B. 
pertussis or HSF;  saline-treated  mice served as controls  (Table  II). Of all  the inbred 
strains tested, only SJL, DDD, and SWR showed increased histamine sensitivity after 
B. pertussis treatment.  Outbred  CFW mice also developed  increased  sensitivity.  The 
susceptibility  to  B. pertussis or  HSF-induced  histamine  sensitivity  is  inherited  in  a 
dominant  fashion  as indicated  by the responses of (SJL  ×  BALB/c)Fa and  (B10.Q 
×  DDD)F1 hybrids (B10.Q are not sensitive to HSF; see Table III). 
Correlation of EAE and HSF Sensitivity.  Inbred, outbred, and recombinant strains of 
mice were evaluated  for EAE susceptibility  and B. pertussis-induced  histamine  sensi- 
tivity (Table III). In each case histological and clinical indices of EAE are presented, 
and  in  separate  experiments,  histamine-induced  deaths  3  d  after  administration  of 
B. pertusis vaccine  are  recorded.  SJL,  SWR,  and  CFW  all  developed  EAE  and  in- 
creased histamine sensitivity in response to B. pertussis. BALB/c, CBA, C57BL/6, and 
DBA/1 did not develop EAE nor histamine sensitivity. Outbred CFW mice developed 
both EAE and histamine sensitivity. 
To determine  if the susceptibility  of EAE and VAAS is controlled  by H-2 genes, 
several H-2 congenic and recombinant strains were examined. All strains resistant  to 
EAE  were  also  resistant  to  VAAS.  However,  in  several  strains  such  as  B10.S, 
B10.T(6R),  B10.S(7R),  and  B10.HTT,  some  individual  mice  developed  EAE  and 34  ACUTE AUTOIMMUNE  ENCEPHALOMYELITIS IN  MICE 
TABLE II 
Histamine  Sensitization in Mice Given HSF or B. pertussis  Vaccine 
Number of deaths/total  tested* 
Mouse strain  HSF 
150  75  30 
B. pertussis  Saline 
(5 ×  101°) 
#g 
C57BL/6  0/5  0/5  0/5  0/5  0/5 
AKR  0/5  0/5  0/5  0/5  0/5 
CBA  0/5  0/5  0/5  0/5  0/5 
A/J  1/5  0/5  0/5  0/5  0/5 
BALB/c  0/5  0/5  0/5  0/5  0/5 
SJL  5/5  2/6  2/5  9/12  0/10 
CFW  6/6  3/5  --  9/10  0/5 
DBA/1  0/10  --  --  1/10  0/8 
SWR  --  --  --  6/6  0/6 
DDD  1/6  2/5  --  6/7  0/6 
(SJL x BALB/c)F1  4/4  4/4  1/6  6/6  0/10 
(SOIL x SWR)F1  6/6  5/6  --  6/6  0/4 
(BI0.QXDDD)F1  2/5  1/6  --  4/6  0/6 
* Data are expressed as number of deaths/total  tested 3 d after administration of 
HSF, pertussis, or saline; challenge was  1 mg histamine-free base i.p. with the 
exception of SJL, which was given only 0.1 mg. 
some  were  sensitive  to  B.  pertussis-induced  histamine  sensitivity;  the  reason  for 
variation within the  strain is  not known. It  is not  possible to  correlate the  two  in 
individuals because both traits cannot be tested in a  single mouse. 
The susceptibility to EAE and VAAS in F1 hybrid mice was also examined (Table 
IV).  Both  EAE  and VAAS  appear  to  be  inherited in a  codominant fashion.  SJL, 
SWR, and CFW hybrids with nonresponder strains  (BALB/c or NZB)  were  deter- 
mined to be susceptible to both EAE and VAAS. Hybrids produced between EAE- 
resistant/VAAS mice (e.g., DDD)  and strains that were susceptible to neither EAE 
nor VAAS (e.g., B10.S, B10.HTT, or B10.Q) were susceptible to EAE and VAAS. 
Discussion 
The immune response to protein antigens are generally regulated in part by MHC 
genes,  probably  Ia  antigens  (1).  However,  in  experimental  autoimmune  disease 
models, such as EAE, it is clear that non-MHC genes play an important role in the 
susceptibility to  the  disease  (14,  15).  EAE  is  complicated  by  the  fact  that  the 
experimental readout is not merely the production of a  single antibody or restricted 
cytotoxic T  cell response. Rather, the overall expression of the disease is the result of 
a well orchestrated concert of effector cells, immune factors, and tissue responses. The 
mouse EAE model has been examined for almost  20 yr  (6),  and still there  is great 
disagreement regarding the factor(s) that control the induction and expression of the 
disease. 
In a companion paper, we have carefully documented the role that B. pertussis plays 
as  an  effector  adjuvant in the  expression  of murine EAE.  2 In our  laboratory this 
Linthicum, D. S., J. J. Munoz, and A. Blaskett. Acute experimental autoimmune encephalomyelitis  in 
mice. I. The adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased 
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TAaLE  III 
Incidence of Acute EAE and Histamine Sensitization in Inbred, Outbred, and Recombinant Strains of Mice 
H-2  Composition of H-2 region  EAE index*  Histamine 
Strain  sensitiza- 
type  K  IA  IB  IC  S  D  Clinical  Histological  tion¢ 
Inbred 
C57BL/6  b  b  b  b  b  b  b  0.0 O/I0)  0.0 (0/10)  0/6 
DBA/1  q  q  q  q  q  q  q  0.0 (0/3)  0.0 (0/3)  1/10 
SJL  s  s  s  s  s  s  s  1.8 (7/10)  --  12/12 
SWR  q  q  q  q  q  q  q  1.8 (3/5)  1.6 (4/5)  6/6 
DDD  UD§  s  s  ?  ?  ?  ?  0.2 (2/12)  0.2 (2/12)  6/7 
Outbred 
CFW  s/q  s  ?  ?  ?  ?  q  1.7 (9/15)  0.8 (8/14)  10/10 
Recombinant 
A.SW  s  s  s  s  s  s  s  0.0 (0/20)  0.0 (0/20)  0/10 
A.TH  t2  s  s  s  s  s  d  0.0 (0/5)  0.4 (1/5)  1/10 
A.TL  tl  s  k  k  k  k  k  0.0 (0/20)  0.0 (0/20)  0/10 
B10.S  s  s  s  s  s  s  s  0.0 (0/9)  0.2 (2/9)  6/11 
B10.A  a  k  k  k  d  d  d  0.0 (0/4)  0.1  (1/4)  0/7 
B10.Q  q  q  q  q  q  q  q  0.0 (0/14)  0.0 (0/6)  5/16 
B10.HTT  t3  s  s  s  k  k  d  0.1  (1/14)  0.1  (1/14)  2/17 
B10.T(6R)  yl  q  q  q  q  q  d  0.3 (2/11)  0.4 (3/10)  6/16 
B10.S(7R)  t2  s  s  s  s  s  d  0.2 (4/22)  0.2 (3/20)  6/14 
B10.S(SR)  asl  k  k  ?  s  s  s  0.0 (0/7)  0.0 (0/7)  0/7 
A.TFR- 1  an 1  s  k  k  k  k  f  0.0 (0/4)  0.0 (0/4)  0/6 
* EAE indices are expressed as mean values (maximum = 3.0). Parenthetical values are numbers of affected 
individuals/total tested. 
:]: Expressed  as deaths/total tested after challenge with 1 mg histamine 3 d after administration of 101° B. 
pertussis cells. 
§ Undesignated. 
adjuvant  is crucial  to  the  successful  production  of acute  EAE  and  its success  as  an 
adjuvant  relies upon  the  HSF  content.  With  these  aspects  in  mind  we  examined  a 
wide  variety  of mouse  strains  for  susceptibility  to  EAE  and  HSF  sensitivity.  The 
results presented  herein clearly indicate that  the susceptibility to EAE is conferred by 
the presence of the appropriate  responder  1-1-2 haplotype  and  the presence of a  non- 
H-2 gene(s), which controls the susceptibility  to HSF. 
In Table V  we have summarized  the data from  11 publications  (1, 2, 6, 7, 9,  11-13, 
17,  18,  23),  including  this  report,  on  murine  EAE,  and  have  compared  these  data 
with  published  reports  (6,  9,  11,  13,  23,  24)  on  susceptibility  to  B. pertussis-induced 
histamine  sensitivity.  The  overall analysis  reveals a  positive correlation  between  the 
two phenomena.  There  are a  few disagreements  regarding  the susceptibility  to  EAE 
or HSF in certain strains, but these for the most part  are in the minority of published 
reports (7,  11-13,  17,  18). Differences in results from different laboratories may depend 
upon  the  route  of injection  of the  encephalitogen,  source  of the  encephalitogenic 
material  (allogenic  or  syngeneic  spinal  cord),  and  exact  derivation  of each  mouse 
strain  tested.  In  addition,  of course,  the  nature  of the  adjuvant  B.  pertussis  is  quite 
variable; we have observed that  different strains and batches can vary with respect to 
the amount  of HSF activity. Furthermore,  Munoz  and Bergman  (26) have determined 
that  the degree of HSF  responsiveness  of CFW  mice alters  during  the year,  and  can 36  ACUTE AUTOIMMUNE ENCEPHALOMYELITIS  IN MICE 
TAnLE IV 
Incidence of Clinical and Histological EAE and Histamine Sensitization in F1 Hybrid Mice 
EAE index  Histamine sen- 
Strain  H-2 genotype  sitization 
Clinical  Histological 
(SJL × BALB/c)F1  s/d  2.3 (10/11)  2.3 (9/9)  10/10 
(SJL × NZB)Fa  s/d  2.3 (11/12)  2.4 (i  1/1 i)  10/10 
(SJL × SWR)Fx  s/d  2.0 (9/12)  --  6/6 
(SJL x CFW)F:  s/s,q  2.8 (10/10)  2.9 (7/7)  9/9 
(CFW X BALB/c)F:  s,q/d  1.3 (5/8)  1.0 (4/7)  6/6 
(CFW X B10.S)Fa  s,q/s  0.4 (3/10)  0.9 (7/10)  5/6 
(CFW × A.SW)Fx  s,q/s  2.4 (9/9)  1.6 (4/5)  3/8 
(SWR × A.SW)F~  q/s  1.6 (5/8)  1.4 (4/7)  6/6 
(SWR × B10.S)F:  q/s  1.5 (6/8)  1.7 (6/6)  7/7 
(DDD × BI0.Q)F1  K~I~D~/q  1.2 (9/14)  2.0 (9/14)  4/6 
(DDD × B10.S)Fx  K'I'D~/s  1.5 (11/12)  0.8 (9/12)  -- 
(DDD x B10.HTT)Fa  K"I'D~/t3  2.3 (15/16)  2.4 (15/16)  -- 
(C57B1/6) × B10.Q)F1  b/q  0.0 (0/4)  0.0 (0/4)  -- 
EAE index numbers are means for each group. Proportion of  affected mice shown in parenthesis. Histamine 
sensitization numbers are expressed as deaths/total  individuals tested by injection of 1.0 mg histamine i.p. 
3 d after administration of B. pertussis (101° cells). 
vary with  environmental  stress  and  age  of the  animals.  Genetic  drift  of the  HSF 
response  gene in each mouse colony may also account for different  results  between 
laboratories  using  the  same  strain  over the  years.  With  respect  to  the  H-2  genetic 
contribution, it is clear that H-2 contributes to susceptibility.  However, susceptibility 
is  not  expressed  unless  complemented  with  the  HSF  response  gene.  For  example, 
Lando et al.  (18)  reported that SJL and (SJL ×  BALB/c)F: mice were susceptible to 
EAE, but that A.SW and B 10.S and F: hybrids with BALB/c were not susceptible to 
EAE. They concluded that EAE was not influenced by H-2. We have observed that 
A.SW, B10.S, and  BALB/c are fairly resistant  to VAAS induced by B. pertussis and 
therefore, none of the Fa hybrids produced with these parental  strains have the HSF 
response  gene, nor do they develop EAE, even though they possess  the appropriate 
responder  H-2  gene.  Montgomery  and  Rauch  (27)  have  also  reported  that  EAE 
responsiveness  is  under  the  primary control of genes  outside  the  H-2 complex and 
present data indicating that a maternal factor, sex hormone, or sex-linked gene(s) can 
modify EAE responsiveness.  We  have observed  (unpublished)  that  SJL male  mice 
subject  to excessive fighting behavior do not develop EAE as readily as docile, age- 
matched, females, or docile, age-matched, castrated males. 
In  the  present  study,  the  H-2  control  of susceptibility  to  EAE  appears  to  be 
mediated  by the D-end of the H-2 complex.  For example,  the DDD strain  does not 
develop  EAE,  in  spite  of having  KSI-A  s  alleles,  presumably  because  it  lacks  the 
appropriate  D  allele.  However,  F1 hybrids between  DDD and  B10.S,  B10.HTT,  or 
B10.Q possess the D s, D d, or D q allele, respectively, and are fully susceptible to EAE, 
suggesting that D ~, D d, or D q is necessary to confer susceptibility. This D  region allelic 
requirement  may control the overall response to the adjuvant used in the encephalit- 
ogenic challenge. Staruch and Wood (28) reported that murine responses to muramyl 
dipeptide were controlled by at least two genes, one inside and one outside the MHC; 
H-2  d and  H-2  k were high  responders  to the  muramyl  dipeptide.  We have  recently 
produced  EAE  in  the  SJL  ×  BALB/c  recombinant  inbred  strain  C  ×  J1  (kindly D.  S.  LINTHICUM  AND J.  A.  FRELINGER  37 
TABLE V 
Summary of thtbtished Observations on Murine EAE Susceptibility and B. pertussis-induced Histamine 
Sensitivity 
VAA hyper-  Mouse  H-2 type  EAE suscep-  Reference  Reference 
Strain  tibility  sensitivity 
A/J  a  -  7, 12, 18  -  23, 24* 
BALB/c  d  -  7, 9, 12, 17, 18  -(+)  (24)* 
C57B1/6J  b  -(+)  23 (7, 12, 18)*  -(+)  (9)* 
C57B1/10  b  -  7, 17  ? 
C57L/J  h  +  7  +  23 
C3H/J  k  -(+)  7, 12, 23 (11,  13)  -  13, 24 
CBA  k  -  7,  12  -  24* 
DBA/1  q  -(+)  7, 9 (17)*  -  * 
DBA/2  d  -  7, 18  -(+)  23 (24) 
DDD  (K'I'D  ~)  -  11"  +  11, 13" 
NBZ  d  -  1, 2,  12, 18  -  24 
NZC  d  -  12  ? 
SJL/J  s  +  7, 11, 12, 13, 17, 18"  +  11, 13" 
SWR  q  +  7*  +  24* 
CFW  s/q  +  7, 23*  +  23* 
A.SW  s  -(+)  9,  11, 18 (12, 17)*  -  * 
A.TH  th  -(+)  (12,  17)*  -  * 
A.TL  tl  -(+)  (12,  17)*  -  * 
A.TFR - 1  an 1  -  *  -  * 
B10.A  a  -  7, 12, 18"  -  * 
B10.S  s  2:(+)  7, 9, 18 (17)*  2:  * 
B10.Q  q  -  7, 9,  18"  ~  * 
B10.HTT  t3  :1:  *  2:  * 
B10.T(6R)  yl  ±  *  2:  * 
B10.S(7R)  t2  2:  *  2:  * 
B10.S(8R)  asl  -  *  -  * 
BRVR  k  -  6, 7,  12  -  6 
BSVS  +5  +(-)  6 (7)  +  6 
Observations for EAE susceptibility and VAA hypersensitivity induced by B. pertussis are recorded as + 
(positive)  and --  (negative). Where there are minor conflicting reports, the parenthetical observations 
and references are indicated. 
* Indicates data presented in this paper. 
provided  by Dr.  Mel  Cohn,  Salk Institute  for Biological  Studies), which  is H-2  d  and 
HSF  sensitive (unpublished  observations);  these preliminary  data  support  the notion 
that  H-2  d is a  responder  haplotype,  and, when  complemented  with the HSF  response 
gene, confers susceptibility to EAE. 
In mice, the expression of DTH  responses is controlled by VAA, especially serotonin 
(29).  The  role  of  VAA  is  to  allow  the  egress  of  sensitized  T  lymphocytes  and 
nonsensitized mononuclear  cells from  the rnicrovasculature  to the antigen  depot  site 
(30).  Most  likely  the  same  sequence  of events  is  true  for  the  action  of VAA  in  the 
expression of murine  EAE.  The  observations reported  in a  companion  paper  support 
this notion, in that  we have  demonstrated  VAA  antagonists  such as cyproheptadine 
and  methysergide  can  effectively  block  the  development  of acute  EAE. 2 It  must  be 
noted  that  throughout  this  and  the  companion  paper  we  have  emphasized  that  B. 
pertussis and VAAS  are important  in the expression of acute EAE  in mice. This point 
has  been  intentional,  in  that  it  has  been  reported  by  several  laboratories  (31)  that 38  ACUTE AUTOIMMUNE ENCEPHALOMYELITIS IN MICE 
chronic EAE in mice can be produced in SJL mice only in the absence of B. pertussis 
or  by  giving  the  vaccine with  the  encephalitogenic  emulsion  intradermally.  The 
different forms of EAE have been best documented for the rat  (32), in which three 
well-recognized types of EAE exist: (a) hyperacute EAE, characterized by hemorrhage, 
fibrin deposition, edema, and presence of polymorphonuclear cells, and is dependent 
upon B. pertussis,  more specifically HSF, which alters CNS vascular permeability (33); 
(b) acute EAE;  and  (c) chronic, relapsing EAE. In mice only two forms, acute and 
chronic EAE, have been reported. The acute EAE of mice, however, may be closely 
related to the "hyperacute" EAE observed in rats, in that the disease is dependent 
upon B. pertussis,  especially HSF, the CNS vascular permeability increases, and some 
polymorphonuclear cells are occasionally present in the lesions. Chronic EAE has only 
been observed in  the  SJL mouse  (31).  As  indicated  in  Table  I, and  supported by 
previous workers (24), the SJL mouse is a priori very sensitive to VAA- (both histamine 
and  serotonin)  induced shock, whereas other strains examined are highly resistant. 
The gene(s) controlling natural VAA sensitivity is probably different than that which 
controls HSF sensitivity, because SJL and  SWR  mice have different natural  VAA 
sensitivities. We postulate that the SJL mouse does not require any additional VAA 
sensitization  to  develop  chronic  EAE,  thereby  accounting  for  the  production  of 
chronic EAE  in  the absence of B.  pertussis.  Because the  inheritance of the  natural 
resistance to VAA-induced shock is dominant, SWR and (SJL ×  BALB/c)Fa hybrids 
should not develop chronic EAE, even though they are fully susceptible to acute EAE 
and HSF sensitivity. Chronic EAE, unlike acute EAE, is probably not accompanied 
by  any  detectable  acute  CNS  vascular  permeability  change  mediated  by  VAA 
antecedent  to  the  cellular  infiltration  of the  CNS,  and  may  be  due  to  the  slow 
penetration of effector cells over a prolonged period of time. 
Summary 
The  expression of acute  experimental  autoimmune  encephalomyelitis  (EAE)  in 
mice is controlled by several dominant genes, H-2 and histamine sensitization genes. 
SJL/J and  SWR/J, which are H-2  s and  H-2  q, respectively, are susceptible to EAE 
and sensitive to Bordetella pertussis  histamine-sensitizing factor (HSF), which produces 
a vasoactive amine hypersensitivity. Other H-2  s or H-2  q strains such as A.SW, B 10.Q, 
and several others do not develop acute EAE and are not sensitive to B. pertussis HSF. 
One  strain  tested,  DDD  (K'ISD  ?)  is  HSF  sensitive  but  does  not  develop  EAE 
(presumably because it lacks the appropriate responder H-2 haplotype). However, F1 
hybrids  between  B10.S  and  DDD  are  sensitive  to  HSF  and  develop  EAE.  The 
induction and effector phases of acute EAE are apparently controlled by the combi- 
nation  of H-2  and  HSF  genes.  A  combination  of the  correct  H-2  hapotype  and 
histamine sensitivity is required for the development of acute EAE. 
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